Tribunal directs re-examination of arm's-length price, excludes non-comparable companies & reclassifies software fees

The appeal was partly allowed by the Tribunal, directing the Assessing Officer/Transfer Pricing Officer to re-examine the arm's-length price (ALP) after excluding non-comparable companies and treating software license fees as revenue expenditure. The Tribunal's decision was supported by the exclusion of functionally non-comparable companies and the reclassification of software license fees, leading to the deletion of an addition to the total income.

---

---

Issues Involved:
1. Determination of the arm's-length price (ALP) for the appellant's international transactions.
2. Disregard of the appellant's Transfer Pricing (TP) documentation.
3. Use of financial data of only the current year for benchmarking.
4. Rejection of a comparable company due to significant related party transactions.
5. Identification of functionally non-comparable companies.
6. Granting of ±5% benefit under the proviso to Section 92C(2) of the Act.
7. Treatment of software license fees as capital expenditure.
8. Addition to the total income due to the above treatment.

Detailed Analysis:

1. Determination of ALP for International Transactions:
The appellant's international transaction of contract research and testing services was initially determined at Rs. 447,599,531. However, the Assessing Officer (AO) adjusted this to Rs. 480,668,153. The appellant argued that the Transfer Pricing Officer (TPO) included four additional comparables that were not functionally similar to the appellant's activities. The Tribunal, following its earlier decision for the assessment year 2007-08, excluded three of these comparables (Celestial Labs Ltd., IDC (India) Ltd., and Mindtree Ltd. - Segmental) due to their diversified operations and functional dissimilarity. The Tribunal directed the AO/TPO to re-examine the working of the ±5% margin range after excluding these comparables.

2. Disregard of TP Documentation:
Grounds 2, 3, and 4 were not pressed by the appellant and were dismissed as not pressed.

3. Use of Financial Data of Only the Current Year:
This issue was also not pressed by the appellant and thus dismissed.

4. Rejection of Comparable Due to Related Party Transactions:
The TPO rejected Neeman Medical Intl. (Asia) Ltd. Clinical Research due to significant related party transactions (36.70%). The Tribunal upheld this rejection as it aligned with the established guidelines for comparability.

5. Identification of Functionally Non-Comparable Companies:
The Tribunal analyzed the functional profiles of the comparables identified by the TPO. It found that Celestial Labs Ltd., IDC (India) Ltd., and Mindtree Ltd. (Segmental) were not functionally comparable to the appellant due to their diversified operations and involvement in different industries. The Tribunal excluded these comparables from the benchmarking analysis.

6. Granting of ±5% Benefit:
The Tribunal directed the AO/TPO to re-examine the appellant's claim for the ±5% benefit under the proviso to Section 92C(2) of the Act, after excluding the non-comparable companies. This direction was given since the exclusion of the three comparables would bring the arithmetic mean of the remaining comparables within the ±5% range of the ALP.

7. Treatment of Software License Fees as Capital Expenditure:
The appellant claimed Rs. 33,22,798 towards software license fees as revenue expenditure. The AO treated this as capital expenditure, allowing depreciation at 60%, resulting in an addition of Rs. 13,29,119 to the total income. The Tribunal, after considering the nature of the expenditure and the purpose of the software licenses, held that the expenditure was for the efficient running of the existing computer systems and did not create any new asset. Therefore, it should be treated as revenue expenditure. The Tribunal directed the AO to allow the expenditure as revenue expenditure.

8. Addition to Total Income:
Consequently, the Tribunal directed the deletion of the addition of Rs. 13,29,119 to the total income due to the reclassification of the software license fees as revenue expenditure.

Conclusion:
The appeal was partly allowed, with directions to the AO/TPO to re-examine the ALP after excluding the non-comparable companies and to treat the software license fees as revenue expenditure. The Tribunal's decision was based on a detailed analysis of the functional profiles of the comparables and the nature of the software license expenditure.

---